Personalised nutrition guru on women's role in research

This content item was originally published on www.nutraingredients-usa.com, a William Reed online publication.

By Danielle Masterson

- Last updated on GMT

Mariëtte Abrahams is the CEO and founder of Qina – a platform that helps companies connect and innovate in personalized nutrition. Qina provides market intelligence, research and innovation services through products and specialist consultancy services via a global network of domain experts. Abrahams has worked in the clinical and medical nutrition industry for over 20 years and leverages her combined expertise in nutrition, business and research to help businesses create the next generation of nutrition solutions.

Abrahams​ said that it's not only the types of foods but the timing of when one eats thar plays a major role.

“If we can have more people being aware about the impact of food and the benefits, and the potential on their health, than anybody would be driven by data, everybody loves data. And of course that could help behavior change–that's the key point in personalized nutrition and that is the hardest to change."

She added that a major challenge is that most of the clinical trials are done in big cities and at university hospitals.

“Women's health at the moment ranks the highest in the number of decentralized trials and that is simply because we have very poor scientific data of women being included historically, in scientific evidence. So whether that's in chronic diseases, whether it’s in performance, whether it’s menopause, we have very little data,”​ noted Abrahams.

But on the bright side, we do have technology, she noted. “So you can have your wearable, you can have your glucose monitor, you can have your online survey, you can have teleconferencing and women are increasingly– irrespective of where they are in their cycle or in their lives– can now participate at their own convenience in these clinical trials. And so now we see not only because of the interest in women's health, but from an investment point of view and the technology point of view, where women want products for women because we need the science, we also need evidence-based and we need it designed for women's physiology,​” said Abrahams.

Related news

Show more

Related products

show more

Unlock sensory innovation with AromatiQ™ technology

Unlock sensory innovation with AromatiQ™ technology

Content provided by Lonza | 20-Sep-2024 | Product Brochure

With 70% of consumers willing to pay a premium for a more enjoyable and memorable supplement experience, Lonza’s new AromatiQ™ technology enables brands...

From Biofarma a clinically tested vaginal protection

From Biofarma a clinically tested vaginal protection

Content provided by Biofarma Group | 05-Sep-2024 | Product Brochure

Bacterial vaginosis is considered the most common cause of vaginal infection among pregnant and non-pregnant women. In this scenario, the oral intake of...

Research to Reality: Restorative Sleep

Research to Reality: Restorative Sleep

Content provided by Gencor | 02-Sep-2024 | White Paper

Gencor prides itself on its cutting-edge, science-driven solutions. Explore sleep support through gold-standard, clinically-validated dietary supplement...

Ingredients to support women at every life stage

Ingredients to support women at every life stage

Content provided by Gencor | 21-Jun-2024 | White Paper

While addressing women’s health across all stages of life, we might as well have opened Pandora’s box. Dietary supplements can play an important role in...

Related suppliers

Follow us

Products

View more

Webinars